Sort
21,453 grants matching “tuberculosis”
The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection
$617,464Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2019 · AI
The role of non-classical MHC class I molecules in immune responses to Mycobacterium tuberculosis infection
$617,464Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2020 · AI
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis
$617,457Leah Elizabeth Cowen · University Of Toronto · R01 · FY2025 · AI
Predicting tuberculosis outcomes using genotypic and biomarker signatures
$617,451Gillian L Beamer · Tufts University Boston · R01 · FY2019 · HL
INH-induced lysis of the HIV OI, M. tuberculosis
$617,440Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2005 · AI
Spatially mapping and modeling tuberculosis granulomas to define the immunological determinants of infection outcome
$617,358Erin McCaffrey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome
$617,255Christoph Grundner · Seattle Children'S Hospital · R01 · FY2023 · AI
Longitudinal Study of HIV-Associated Lung Infections in Soweto
$617,155Richard E Chaisson · Johns Hopkins University · R01 · FY2007 · HL
Host Response to TB and AIDS
$617,040New York University School Of Medicine · R01 · FY2003 · HL
The effect of inflammation and damage to lymph node structures on durable protective immunity following vaccination
$616,774Timothy W Schacker · University Of Minnesota · U01 · FY2019 · AI
Drug tourism to Mexico: Impact of Mexicos new drug law on HIV-HCV-TB in US IDUs
$616,726Richard S Garfein · University Of California, San Diego · R01 · FY2013 · DA
REGULATION OF LIPID METABOLISM IN BACTERIA
$616,721Charles O Rock · St. Jude Children'S Research Hospital · R37 · FY2007 · GM
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$616,559Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Etiology of Persistent Microalbuminuria in Nigeria
$616,525William Wester · Vanderbilt University Medical Center · R01 · FY2021 · DK
Functional dynamics of TB granuloma architecture
$616,269Joel D. Ernst · University Of California, San Francisco · U01 · FY2024 · AI
Administrative Core
$616,131Megan B Murray · Harvard Medical School · U19 · FY2017 · AI
DEVELOPMENT AND TESTING OF NEW TUBERCULOSIS VACCINES
$616,092University Of California Los Angeles · R01 · FY2004 · AI
Expression signatures of TB-specific memory responses within the human lung
$616,090Richard F Silver · Case Western Reserve University · R01 · FY2015 · HL
A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection Outcomes
$616,042Jason Edward Farley · Johns Hopkins University · R01 · FY2017 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$615,897Ann R Falsey · University Of Rochester · UM1 · FY2020 · AI
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
$615,827Volker Briken · Univ Of Maryland, College Park · R01 · FY2023 · AI
Molecular mechanisms of host cell escape by Mycobacterium tuberculosis
$615,827Volker Briken · Univ Of Maryland, College Park · R01 · FY2022 · AI
Immune correlates of LTBI in HIV-exposed infants
$615,772Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2020 · AI
Functional dynamics of TB granuloma architecture
$615,683Joel D. Ernst · University Of California, San Francisco · U01 · FY2023 · AI
Epidemiology of multidrug-resistant tuberculosis in Peru
$615,660Mercedes C Becerra · Harvard Medical School · R01 · FY2008 · AI